Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
7.05
-0.09 (-1.26%)
Apr 29, 2026, 4:08 PM HKT
Jacobio Pharmaceuticals Group Employees
Jacobio Pharmaceuticals Group had 196 employees as of December 31, 2025. The number of employees decreased by 61 or -23.74% compared to the previous year.
Employees
196
Change (1Y)
-61
Growth (1Y)
-23.74%
Revenue / Employee
303.89K HKD
Profits / Employee
-828.82K HKD
Market Cap
5.53B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ocumension Therapeutics | 552 |
| Laekna | 83 |
| Beijing Luzhu Biotechnology | 205 |
| CK Life Sciences Int'l., (Holdings) | 1,935 |
| Shandong Boan Biotechnology | 714 |
| Qyuns Therapeutics | 337 |
| Clover Biopharmaceuticals | 243 |
| TYK Medicines | 173 |
Jacobio Pharmaceuticals Group News
- 4 months ago - Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73 - PRNewsWire
- 7 months ago - Jacobio Pharma Announces Strategic Partnership with Oceanpine Capital to Focus on Core Oncology Pipeline - PRNewsWire
- 8 months ago - Jacobio Pharma Announces 2025 Interim Results - PRNewsWire
- 10 months ago - Jacobio's IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted - PRNewsWire